Regional expansion MilliporeSigma is actively expanding facilities and biosafety testing capabilities in Singapore and Germany, indicating growing demand for contract testing, regulatory-compliant services, and localized supply chain support that sales teams can position to regional customers.

Broad portfolio strength With one of the broadest life science tool and service portfolios and integrated CDMO capabilities, there are cross-sell opportunities across pharmaceutical development, manufacturing, testing, and digitized offerings to existing and new biotech firms.

Sustainability leadership Award recognitions for corporate social responsibility and sustainability leadership suggest a buyer preference for suppliers with ESG commitments, presenting avenues to align solutions with customers’ sustainability goals and reporting needs.

Strategic partnerships As the life sciences arm of a global tech company, MilliporeSigma’s scale and ecosystem enable joint ventures, co-development, and multi-modal testing partnerships that can accelerate customer programs and reduce time-to-market.

Digital and outsourcing trends Investments in digital offerings, cloud-based tools, and a fully integrated service organization indicate opportunities to upsell digital lab solutions, data analytics, remote services, and contract testing across traditional and novel modalities.